Featured Content
Vivex Biologics’ VIA Form+ cryopreserved viable bone allograft saw 100% radiograhpic fusion success within six months of surgery, according to…
Vivex Biologics’ VIA Form+ cryopreserved viable bone allograft saw 100% radiograhpic fusion success within six months of surgery, according to…